{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:00:27Z","timestamp":1783994427984,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/201.441\/2021"],"award-info":[{"award-number":["E-26\/201.441\/2021"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405653\/2021-2"],"award-info":[{"award-number":["405653\/2021-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["23\/2551-0000503-4"],"award-info":[{"award-number":["23\/2551-0000503-4"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"name":"INI\/Fiocruz","award":["INI-003-FIO-19-2-7"],"award-info":[{"award-number":["INI-003-FIO-19-2-7"]}]},{"name":"Programa Inova Fiocruz","award":["PRES-008-FIO-22-2-11"],"award-info":[{"award-number":["PRES-008-FIO-22-2-11"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s42770-024-01301-5","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T15:04:01Z","timestamp":1710169441000},"page":"1359-1368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In vitro activity of the anthelmintic drug niclosamide against Sporothrix spp. strains with distinct genetic and antifungal susceptibility backgrounds"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-6681","authenticated-orcid":false,"given":"Mariana Lucy Mesquita","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-1990","authenticated-orcid":false,"given":"Fernando","family":"Almeida-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9318-6240","authenticated-orcid":false,"given":"Vanessa Brito","family":"de Souza Rabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Nahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-832X","authenticated-orcid":false,"given":"Maria Helena Galdino","family":"Figueiredo-Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4997-8734","authenticated-orcid":false,"given":"Andrea Reis","family":"Bernardes-Engemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-3861","authenticated-orcid":false,"given":"Vanice Rodrigues","family":"Poester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-0080","authenticated-orcid":false,"given":"Melissa Orzechowski","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-8340","authenticated-orcid":false,"given":"Wieland","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-1921","authenticated-orcid":false,"given":"Rosely Maria","family":"Zancop\u00e9-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5875-9886","authenticated-orcid":false,"given":"Susana","family":"Frases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6639-6058","authenticated-orcid":false,"given":"Rodrigo","family":"Almeida-Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"1301_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/mmy\/myu062","volume":"53","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S (2015) Global epidemiology of sporotrichosis. Med Mycol 53:3\u201314","journal-title":"Med Mycol"},{"key":"1301_CR2","doi-asserted-by":"crossref","unstructured":"Albuquerque PC, Fonseca E Fonseca B de P, Zicker F, Zancop\u00e9-Oliveira RM, Almeida-Paes R (2020) Bibliometric assessment and key messages of sporotrichosis research (1945\u20132018). F1000Res 9:654","DOI":"10.12688\/f1000research.24250.1"},{"key":"1301_CR3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.abd.2022.07.001","volume":"97","author":"R Orofino-Costa","year":"2022","unstructured":"Orofino-Costa R, Freitas DFS, Bernardes-Engemann AR, Rodrigues AM, Talhari C, Ferraz CE, Veasey JV, Quintella L, Sousa MSLA, Vettorato R, Almeida-Paes R, de Macedo PM (2022) Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management. An Bras Dermatol 97:757\u2013777","journal-title":"An Bras Dermatol"},{"key":"1301_CR4","unstructured":"World Health Organization (2023) Global report on neglected tropical disease. Available at https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/global-report-on-neglected-tropical-diseases-2023. Accessed 03\/08\/2024"},{"key":"1301_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11046-009-9190-z","volume":"168","author":"IZ Carlos","year":"2009","unstructured":"Carlos IZ, Sass\u00e1 MF, da Gra\u00e7a Sgarbi DB, Placeres MCP, Maia DCG (2009) Current research on the immune response to experimental sporotrichosis. Mycopathologia 168:1\u201310","journal-title":"Mycopathologia"},{"key":"1301_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jof3010006","volume":"3","author":"A Bonifaz","year":"2017","unstructured":"Bonifaz A, Tirado-S\u00e1nchez A (2017) Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. J Fungi 3:6","journal-title":"J Fungi"},{"key":"1301_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/jof8010070","volume":"8","author":"VR Poester","year":"2022","unstructured":"Poester VR, Basso RP, Stevens DA, Munhoz LS, Rabello VBS, Almeida-Paes R, Zancop\u00e9-Oliveira RM, Zanchi M, Benelli JL, Xavier MO (2022) Treatment of human sporotrichosis caused by Sporothrix brasiliensis. J Fungi 8:70","journal-title":"J Fungi"},{"key":"1301_CR8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13671-022-00358-5","volume":"11","author":"B Sharma","year":"2022","unstructured":"Sharma B, Sharma AK, Sharma U (2022) Sporotrichosis: a comprehensive review on recent drug-based therapeutics and management. Curr Dermatol Rep 11:110\u2013119","journal-title":"Curr Dermatol Rep"},{"key":"1301_CR9","doi-asserted-by":"crossref","first-page":"893501","DOI":"10.3389\/fcimb.2022.893501","volume":"12","author":"AR Bernardes-Engemann","year":"2022","unstructured":"Bernardes-Engemann AR, Tomki GF, Rabello VBS, Almeida-Silva F, Freitas DFS, Gutierrez-Galhardo MC, Almeida-Paes R, Zancop\u00e9-Oliveira RM (2022) Sporotrichosis caused by non-wild type Sporothrix brasiliensis strains. Front Cell Infect Microbiol 12:893501","journal-title":"Front Cell Infect Microbiol"},{"key":"1301_CR10","first-page":"507","volume":"55","author":"R Almeida-Paes","year":"2017","unstructured":"Almeida-Paes R, Oliveira MME, Freitas DFS, Valle ACF, Gutierrez-Galhardo MC, Zancop\u00e9-Oliveira RM (2017) Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Med Mycol 55:507\u2013517","journal-title":"Med Mycol"},{"key":"1301_CR11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/jof8101004","volume":"8","author":"LP Borba-Santos","year":"2022","unstructured":"Borba-Santos LP, Rollin-Pinheiro R, da Silva FY, Dos Santos GMP, de Sousa Ara\u00fajo GR, Rodrigues AM, Guimar\u00e3es AJ, de Souza W, Frases S, Ferreira-Pereira A, Barreto-Bergter E, Rozental S (2022) Screening of pandemic response box library reveals the high activity of olorofim against pathogenic Sporothrix species. J Fungi 8:1004","journal-title":"J Fungi"},{"key":"1301_CR12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/pathogens11020206","volume":"11","author":"GMP Dos Santos","year":"2022","unstructured":"Dos Santos GMP, Borba-Santos LP, Vila T, Gremi\u00e3o IDF, Pereira SA, De Souza W, Rozental S (2022) Sporothrix spp. Biofilms impact in the zoonotic transmission route: feline claws associated biofilms, itraconazole tolerance, and potential repurposing for miltefosine. Pathogens 11:206","journal-title":"Pathogens"},{"key":"1301_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358","journal-title":"Nat Rev Drug Discov"},{"key":"1301_CR14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"JR Perfect","year":"2017","unstructured":"Perfect JR (2017) The antifungal pipeline: a reality check. Nat Rev Drug Discov 16:603\u2013616","journal-title":"Nat Rev Drug Discov"},{"key":"1301_CR15","first-page":"174569","volume":"912","author":"N Mittal","year":"2021","unstructured":"Mittal N, Mittal R (2021) Repurposing old molecules for new indications: Defining pillars of success from lessons in the past European. J Pharmacol 912:174569","journal-title":"J Pharmacol"},{"key":"1301_CR16","doi-asserted-by":"crossref","first-page":"e16443","DOI":"10.7717\/peerj.16443","volume":"11","author":"VR Poester","year":"2023","unstructured":"Poester VR, Hidalgo JED, Jardim LS, Tr\u00e1paga MR, Rabello VBS, Almeida-Paes R, Zancope-Oliveira RM, Xavier MO (2023) Amlodipine and lufenuron as repurposing drugs against Sporothrix brasiliensis. PeerJ 11:e16443","journal-title":"PeerJ"},{"key":"1301_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17460441.2022.2080195","volume":"17","author":"W Lim","year":"2022","unstructured":"Lim W, Verbon A, van de Sande W (2022) Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an open source drug discovery approach. Expert Opin Drug Discov 17:641\u2013659","journal-title":"Expert Opin Drug Discov"},{"key":"1301_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1099\/jmm.0.000041","volume":"64","author":"LP Borba-Santos","year":"2015","unstructured":"Borba-Santos LP, Gagini T, Ishida K, de Souza W, Rozental S (2015) Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. J Med Microbiol 64:415\u2013422","journal-title":"J Med Microbiol"},{"key":"1301_CR19","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/myc.13629","volume":"66","author":"VR Poester","year":"2023","unstructured":"Poester VR, Munhoz LS, Stevens DA, Melo AM, Tr\u00e1paga MR, Flores MM, Larwood DJ, Xavier MO (2023) Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis. Mycoses 66:898\u2013905","journal-title":"Mycoses"},{"key":"1301_CR20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","volume":"221","author":"EC Weinbach","year":"1969","unstructured":"Weinbach EC, Garbus J (1969) Mechanism of action of reagents that uncouple oxidative phosphorylation. Nature 221:1016\u20131018","journal-title":"Nature"},{"key":"1301_CR21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","volume":"27","author":"Z Li","year":"2017","unstructured":"Li Z, Brecher M, Deng Y-Q, Zhang J, Sakamuru S, Liu B, Huang R, Koetzner CA, Allen CA, Jones SA, Chen H, Zhang N-N, Tian M, Gao F, Lin Q, Banavali N, Zhou J, Boles N, Xia M, Kramer LD, Qin C-F, Li H (2017) Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res 27:1046\u20131064","journal-title":"Cell Res"},{"key":"1301_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","volume":"349","author":"Y Li","year":"2014","unstructured":"Li Y, Li P-K, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ (2014) Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett 349:8\u201314","journal-title":"Cancer Lett"},{"key":"1301_CR23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","volume":"6","author":"J Xu","year":"2020","unstructured":"Xu J, Shi P-Y, Li H, Zhou J (2020) Broad spectrum antiviral agent niclosamide and its therapeutic potential. ACS Infect Dis 6:909\u2013915","journal-title":"ACS Infect Dis"},{"key":"1301_CR24","doi-asserted-by":"crossref","first-page":"e210207","DOI":"10.1590\/0074-02760210207","volume":"116","author":"R Almeida-Paes","year":"2021","unstructured":"Almeida-Paes R, de Andrade IB, Ramos MLM, Rodrigues MVA, Nascimento VA, Bernardes-Engemann AR, Frases S (2021) Medicines for Malaria Venture COVID Box: a source for repurposing drugs with antifungal activity against human pathogenic fungi. Mem Inst Oswaldo Cruz 116:e210207","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1301_CR25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/jof8080776","volume":"8","author":"AM Rodrigues","year":"2022","unstructured":"Rodrigues AM, Gon\u00e7alves SS, de Carvalho JA, Borba-Santos LP, Rozental S, Camargo ZP (2022) Current progress on epidemiology, diagnosis, and treatment of sporotrichosis and their future trends. J Fungi 8:776","journal-title":"J Fungi"},{"key":"1301_CR26","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1080\/22221751.2020.1847001","volume":"9","author":"J Eudes Filho","year":"2020","unstructured":"Eudes Filho J, Santos IBD, Reis CMS, Patan\u00e9 JSL, Paredes V, Bernardes JPRA, Poggiani SDSC, Castro TCB, Gomez OM, Pereira SA, Schubach EYP, Gomes KP, Mavengere H, Alves LGB, Lucas J, Paes HC, Albuquerque P, Cruz LM, McEwen JG, Stajich JE, Almeida-Paes R, Zancop\u00e9-Oliveira RM, Matute DR, Barker BM, Felipe MSS, Teixeira MM, Nicola AM (2020) A novel Sporothrix brasiliensis genomic variant in Midwestern Brazil: evidence for an older and wider sporotrichosis epidemic. Emerg Microbes Infect 9:2515\u20132525","journal-title":"Emerg Microbes Infect"},{"key":"1301_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-7804-5_2","volume":"1775","author":"A Bellemare","year":"2018","unstructured":"Bellemare A, John T, Marqueteau S (2018) Fungal genomic DNA extraction methods for rapid genotyping and genome sequencing. Methods Mol Biol 1775:11\u201320","journal-title":"Methods Mol Biol"},{"key":"1301_CR28","doi-asserted-by":"crossref","first-page":"e0004190","DOI":"10.1371\/journal.pntd.0004190","volume":"9","author":"AM Rodrigues","year":"2015","unstructured":"Rodrigues AM, de Hoog GS, Camargo ZP (2015) Molecular diagnosis of pathogenic Sporothrix species. PLoS Negl Trop Dis 9:e0004190","journal-title":"PLoS Negl Trop Dis"},{"key":"1301_CR29","doi-asserted-by":"crossref","first-page":"e2281","DOI":"10.1371\/journal.pntd.0002281","volume":"7","author":"AM Rodrigues","year":"2013","unstructured":"Rodrigues AM, Teixeira MM, De Hoog GS, Schubach TMP, Pereira SA, Fernandes GF, Lopes-Bezerra LM, Felipe MS, De Camargo ZP (2013) Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks. PLoS Negl Trop Dis 7:e2281","journal-title":"PLoS Negl Trop Dis"},{"key":"1301_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0167-6377(02)00185-2","volume":"31","author":"T Polzin","year":"2003","unstructured":"Polzin T, Daneshmand SV (2003) On Steiner trees and minimum spanning trees in hypergraphs. Oper Res Lett 31:12\u201320","journal-title":"Oper Res Lett"},{"key":"1301_CR31","unstructured":"Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard - second edition. Clinical and Laboratory Standards Institute, Wayne, PA, USA"},{"key":"1301_CR32","first-page":"e01057","volume":"6","author":"A Espinel-Ingroff","year":"2017","unstructured":"Espinel-Ingroff A, Abreu DPB, Almeida-Paes R, Brilhante RSN, Chakrabarti A, Chowdhary A, Hagen F, C\u00f3rdoba S, Gonzalez GM, Govender NP, Guarro J, Johnson EM, Kidd SE, Pereira SA, Rodrigues AM, Rozental S, Szeszs MW, Ballest\u00e9 Alaniz R, Bonifaz A, Bonfietti LX, Borba-Santos LP, Capilla J, Colombo AL, Dolande M, Isla MG, Melhem MSC, Mesa-Arango AC, Oliveira MME, Panizo MM, Camargo ZP, Zancope-Oliveira RM, Meis JF, Turnidge J (2017) Multicenter, international study of MIC\/MEC distributions for definition of epidemiological cutoff values for sporothrix species identified by molecular methods. Antimicrob Agents Chemother 6:e01057-e1117","journal-title":"Antimicrob Agents Chemother"},{"key":"1301_CR33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/mmy\/myu056","volume":"53","author":"LP Borba-Santos","year":"2015","unstructured":"Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, Nucci M, Lopes-Bezerra LM, Ishida K, Rozental S (2015) Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. Med Mycol 53:178\u2013188","journal-title":"Med Mycol"},{"key":"1301_CR34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/CMR.17.2.268-280.2004","volume":"17","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Sheehan DJ, Rex JH (2004) Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 17:268\u2013280","journal-title":"Clin Microbiol Rev"},{"key":"1301_CR35","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Pinz\u00f3n R, Haggerty R, Myrold DD (2012) Measuring aerobic respiration in stream ecosystems using the resazurin-resorufin system. J Geophys Res 117:G00N06","DOI":"10.1029\/2012JG001965"},{"key":"1301_CR36","doi-asserted-by":"crossref","first-page":"e220089","DOI":"10.1590\/0074-02760220089","volume":"117","author":"RA Coelho","year":"2022","unstructured":"Coelho RA, Alves GM, Figueiredo-Carvalho MHG, Almeida-Silva F, de Souza GR, Louren\u00e7o MCS, Brito-Santos F, Amaral ACF, Almeida-Paes R (2022) New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box\u00ae that present synergism with itraconazole. Mem Inst Oswaldo Cruz 117:e220089","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1301_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1","journal-title":"J Antimicrob Chemother"},{"key":"1301_CR38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cellsig.2017.04.001","volume":"41","author":"W Chen","year":"2018","unstructured":"Chen W, Mook RA, Premont RT, Wang J (2018) Niclosamide: beyond an antihelminthic drug. Cell Signal 41:89\u201396","journal-title":"Cell Signal"},{"key":"1301_CR39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jof7030170","volume":"7","author":"A Etchecopaz","year":"2021","unstructured":"Etchecopaz A, Toscanini MA, Gisbert A, Mas J, Scarpa M, Iovannitti CA, Bendez\u00fa K, Nusblat AD, Iachini R, Cuestas ML (2021) Sporothrix brasiliensis: A Review of an emerging south american fungal pathogen, its related disease, presentation and spread in Argentina. J Fungi 7:170","journal-title":"J Fungi"},{"key":"1301_CR40","doi-asserted-by":"crossref","first-page":"e248418","DOI":"10.1136\/bcr-2021-248418","volume":"15","author":"R Rachman","year":"2022","unstructured":"Rachman R, Ligaj M, Chinthapalli S, Serafino-Wani R (2022) Zoonotic acquisition of cutaneous Sporothrix brasiliensis infection in the UK. BMJ Case Rep 15:e248418","journal-title":"BMJ Case Rep"},{"key":"1301_CR41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/antibiotics11050651","volume":"11","author":"V Folliero","year":"2022","unstructured":"Folliero V, Dell\u2019Annunziata F, Roscetto E, Cammarota M, De Filippis A, Schiraldi C, Catania MR, Casolaro V, Perrella A, Galdiero M, Franci G (2022) Niclosamide as a repurposing drug against Corynebacterium striatum multidrug-resistant infections. Antibiotics 11:651","journal-title":"Antibiotics"},{"key":"1301_CR42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/fcp.12583","volume":"35","author":"W Wei","year":"2021","unstructured":"Wei W, Liu H, Yuan J, Yao Y (2021) Targeting Wnt\/\u03b2-catenin by anthelmintic drug niclosamide overcomes paclitaxel resistance in esophageal cancer. Fundam Clin Pharmacol 35:165\u2013173","journal-title":"Fundam Clin Pharmacol"},{"key":"1301_CR43","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/EC.00153-14","volume":"14","author":"MM Teixeira","year":"2015","unstructured":"Teixeira MM, Rodrigues AM, Tsui CKM, Almeida LGP, Van Diepeningen AD, van den Ende BG, Fernandes GF, Kano R, Hamelin RC, Lopes-Bezerra LM, Vasconcelos ATR, de Hoog S, de Camargo ZP, Felipe MSS (2015) Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Eukaryot Cell 14:158\u2013169","journal-title":"Eukaryot Cell"},{"key":"1301_CR44","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1038\/emi.2017.75","volume":"6","author":"L Zhao","year":"2017","unstructured":"Zhao L, Cui Y, Zhen Y, Yao L, Shi Y, Song Y, Chen R, Li S (2017) Genetic variation of Sporothrix globosa isolates from diverse geographic and clinical origins in China. Emerg Microbes Infect 6:e88","journal-title":"Emerg Microbes Infect"},{"key":"1301_CR45","doi-asserted-by":"crossref","first-page":"103743","DOI":"10.1016\/j.fgb.2022.103743","volume":"163","author":"MM Teixeira","year":"2022","unstructured":"Teixeira MM, Almeida-Paes R, Bernardes-Engemann AR, Nicola AM, de Macedo PM, Valle ACF, Gutierrez-Galhardo MC, Freitas DFS, Barker BM, Matute DR, Stajich JE, Zancop\u00e9-Oliveira RM (2022) Single nucleotide polymorphisms and chromosomal copy number variation may impact the Sporothrix brasiliensis antifungal susceptibility and sporotrichosis clinical outcomes. Fungal Genet Biol 163:103743","journal-title":"Fungal Genet Biol"},{"key":"1301_CR46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s42770-020-00297-y","volume":"52","author":"ILR Cruz","year":"2021","unstructured":"Cruz ILR, Freitas DFS, de Macedo PM, Gutierrez-Galhardo MC, Valle ACF, Almeida MA, Coelho RA, Brito-Santos F, Figueiredo-Carvalho MHG, Zancop\u00e9-Oliveira RM, Almeida-Paes R (2021) Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome. Braz J Microbiol 52:5\u201318","journal-title":"Braz J Microbiol"},{"key":"1301_CR47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/mmy\/myw143","volume":"55","author":"KO Sanchotene","year":"2017","unstructured":"Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO (2017) In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases. Med Mycol 55:869\u2013876","journal-title":"Med Mycol"},{"key":"1301_CR48","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.drudis.2014.06.009","volume":"19","author":"SSW Wong","year":"2014","unstructured":"Wong SSW, Samaranayake LP, Seneviratne CJ (2014) In pursuit of the ideal antifungal agent for Candida infections: high-throughput screening of small molecules. Drug Discov Today 19:1721\u20131730","journal-title":"Drug Discov Today"},{"key":"1301_CR49","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/AAC.49.9.3952-3954.2005","volume":"49","author":"L Trilles","year":"2005","unstructured":"Trilles L, Fern\u00e1ndez-Torres B, Dos Santos LM, Wanke B, de Oliveira SA, Almeida-Paes R, Inza I, Guarro J (2005) In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother 49:3952\u20133954","journal-title":"Antimicrob Agents Chemother"},{"key":"1301_CR50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/jof9010049","volume":"9","author":"V Fichman","year":"2022","unstructured":"Fichman V, Almeida-Silva F, Freitas DFS, Zancop\u00e9-Oliveira RM, Gutierrez-Galhardo MC, Almeida-Paes R (2022) Severe Sporotrichosis caused by Sporothrix brasiliensis: Antifungal susceptibility and clinical outcomes. J Fungi 9:49","journal-title":"J Fungi"},{"key":"1301_CR51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/jof8050469","volume":"8","author":"V Fichman","year":"2022","unstructured":"Fichman V, Freitas DFS, Valle ACF, de Souza RV, Curi ALL, Valete-Rosalino CM, de Macedo PM, Varon AG, Figueiredo-Carvalho MHG, Almeida-Silva F, Zancop\u00e9-Oliveira RM, Oliveira RVC, Almeida-Paes R, Gutierrez-Galhardo MC (2022) Severe sporotrichosis treated with amphotericin B: A 20-year cohort study in an endemic area of zoonotic transmission. J Fungi 8:469","journal-title":"J Fungi"},{"key":"1301_CR52","doi-asserted-by":"crossref","first-page":"myac089","DOI":"10.1093\/mmy\/myac089","volume":"60","author":"S Baes Pereira","year":"2022","unstructured":"Baes Pereira S, Dos Reis Gomes A, Bressan Waller S, Batista Xavier JR, Rodrigues AM, Kutscher Ripoll M, Ferreira MRA, Rochedo Concei\u00e7\u00e3o F, Os\u00f3rio de Faria R, Pascoti Bruhn FR (2022) Sporotrichosis in dogs: epidemiological and clinical-therapeutic profile and the emergence of itraconazole-resistant isolates. Med Mycol 60:myac089","journal-title":"Med Mycol"},{"key":"1301_CR53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s42770-020-00290-5","volume":"52","author":"CCT Nakasu","year":"2021","unstructured":"Nakasu CCT, Waller SB, Ripoll MK, Ferreira MRA, Concei\u00e7\u00e3o FR, Gomes ADR, Os\u00f3rio LG, de Faria RO, Cleff MB (2021) Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection. Braz J Microbiol 52:163\u2013171","journal-title":"Braz J Microbiol"},{"key":"1301_CR54","first-page":"73","volume":"52","author":"SB Waller","year":"2021","unstructured":"Waller SB, Dalla Lana DF, Quatrin PM, Ferreira MRA, Fuentefria AM, Mezzari A (2021) Antifungal resistance on Sporothrix species: an overview Braz. J Microbiol 52:73\u201380","journal-title":"J Microbiol"},{"key":"1301_CR55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2334-14-219","volume":"14","author":"AM Rodrigues","year":"2014","unstructured":"Rodrigues AM, de Hoog GS, de C\u00e1ssia PD, Brihante RSN, Sidrim JJC, Gadelha MF, Colombo AL, de Camargo ZP (2014) Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. BMC Infect Dis 14:219","journal-title":"BMC Infect Dis"},{"key":"1301_CR56","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.simyco.2021.100129","volume":"100","author":"JA de Carvalho","year":"2021","unstructured":"de Carvalho JA, Beale MA, Hagen F, Mc F, Kano R, Bonifaz A, Toriello C, Negroni R, Rego RSM, Gremi\u00e3o IDF, Pereira SA, de Camargo ZP, Rodrigues AM (2021) Trends in the molecular epidemiology and population genetics of emerging Sporothrix species. Stud Mycol 100:100129","journal-title":"Stud Mycol"},{"key":"1301_CR57","doi-asserted-by":"crossref","first-page":"e01338","DOI":"10.1128\/AAC.01338-20","volume":"65","author":"SO Abd Algaffar","year":"2021","unstructured":"Abd Algaffar SO, Verbon A, van de Sande WWJ, Khalid SA (2021) Development and validation of an in vitro resazurin-based susceptibility assay against Madurella mycetomatis. Antimicrob Agents Chemother 65:e01338-e1420","journal-title":"Antimicrob Agents Chemother"},{"key":"1301_CR58","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/JCM.02914-12","volume":"51","author":"ACA de Paula e Silva","year":"2013","unstructured":"de Paula e Silva ACA, Oliveira HC, Silva JF, Sangalli-Leite F, Scorzoni L, Fusco-Almeida AM, Mendes-Giannini MJS (2013) Microplate alamarBlue assay for Paracoccidioides susceptibility testing. J Clin Microbiol 51:1250\u20131252","journal-title":"J Clin Microbiol"},{"key":"1301_CR59","first-page":"1475","volume":"28","author":"RB Wescott","year":"1967","unstructured":"Wescott RB (1967) Efficacy of niclosamide in the treatment of Taenia taeniaeformis infections in cats. Am J Vet Res 28:1475\u20131477","journal-title":"Am J Vet Res"},{"key":"1301_CR60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0034-5288(18)33273-9","volume":"22","author":"MA Gemmell","year":"1977","unstructured":"Gemmell MA, Johnstone PD, Oudemans G (1977) The effect of niclosamide on Echinococcus granulosus, Taenia hydatigena and Taenia ovis infections in dogs. Res Vet Sci 22:389\u2013391","journal-title":"Res Vet Sci"},{"key":"1301_CR61","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.3201\/eid2709.203349","volume":"27","author":"SE O\u2019Neal","year":"2021","unstructured":"O\u2019Neal SE, Pray IW, Vilchez P, Gamboa R, Muro C, Moyano LM, Ayvar V, Gavidia CM, Gilman RH, Gonzalez AE, Garcia HH, Cysticercosis Working Group in Peru (2021) Geographically targeted interventions versus mass drug administration to control Taenia solium Cysticercosis, Peru. Emerg Infect Dis 27:2389\u20132398","journal-title":"Emerg Infect Dis"},{"key":"1301_CR62","first-page":"57","volume":"93","author":"R Rodriguez-Canul","year":"1999","unstructured":"Rodriguez-Canul R, Fraser A, Allan JC, Dominguez-Alpizar JL, Argaez-Rodriguez F, Craig PS (1999) Epidemiological study of Taenia solium taeniasis\/cysticercosis in a rural village in Yucatan state, Mexico. Ann Trop Med Parasitol 93:57\u201367","journal-title":"Ann Trop Med Parasitol"},{"key":"1301_CR63","doi-asserted-by":"crossref","first-page":"bio031807","DOI":"10.1242\/bio.031807","volume":"7","author":"DM Cairns","year":"2018","unstructured":"Cairns DM, Boorgu DSSK, Levin M, Kaplan DL (2018) Niclosamide rescues microcephaly in a humanized in vivo model of Zika infection using human induced neural stem cells. Biol Open 7:bio031807","journal-title":"Biol Open"},{"key":"1301_CR64","doi-asserted-by":"crossref","first-page":"114318","DOI":"10.1016\/j.ejmech.2022.114318","volume":"236","author":"T Lu","year":"2022","unstructured":"Lu T, Zheng X, Mao F, Cao Q, Cao Q, Zhu J, Li X, Lan L, Li B, Li J (2022) Novel niclosamide-derived adjuvants elevating the efficacy of polymyxin B against MDR Pseudomonas aeruginosa DK2. Eur J Med Chem 236:114318","journal-title":"Eur J Med Chem"},{"key":"1301_CR65","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/1078-0432.CCR-12-2895","volume":"19","author":"A Wieland","year":"2013","unstructured":"Wieland A, Trageser D, Gogolok S, Reinartz R, H\u00f6fer H, Keller M, Leinhaas A, Schelle R, Normann S, Klaas L, Waha A, Koch P, Fimmers R, Pietsch T, Yachnis AT, Pincus DW, Steindler DA, Br\u00fcstle O, Simon M, Glas M, Scheffler B (2013) Anticancer effects of niclosamide in human glioblastoma. Clin Cancer Res 19:4124\u20134136","journal-title":"Clin Cancer Res"},{"key":"1301_CR66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","volume":"19","author":"P Andrews","year":"1982","unstructured":"Andrews P, Thyssen J, Lorke D (1982) The biology and toxicology of molluscicides, Bayluscide. Pharmacol Ther 19:245\u2013295","journal-title":"Pharmacol Ther"},{"key":"1301_CR67","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.3390\/pharmaceutics14122568","volume":"14","author":"MO Jara","year":"2022","unstructured":"Jara MO, Warnken ZN, Sahakijpijarn S, Thakkar R, Kulkarni VR, Christensen DJ, Koleng JJ, Williams RO (2022) Oral delivery of niclosamide as an amorphous solid dispersion that generates amorphous nanoparticles during dissolution. Pharmaceutics 14:2568","journal-title":"Pharmaceutics"},{"key":"1301_CR68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.11.004","volume":"535","author":"Y Xie","year":"2018","unstructured":"Xie Y, Yao Y (2018) Octenylsuccinate hydroxypropyl phytoglycogen enhances the solubility and in-vitro antitumor efficacy of niclosamide. Int J Pharm 535:157\u2013163","journal-title":"Int J Pharm"},{"key":"1301_CR69","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1016\/j.bmc.2015.07.001","volume":"23","author":"RA Mook","year":"2015","unstructured":"Mook RA, Wang J, Ren X-R, Chen M, Spasojevic I, Barak LS, Lyerly HK, Chen W (2015) Structure-activity studies of Wnt\/\u03b2-catenin inhibition in the niclosamide chemotype: Identification of derivatives with improved drug exposure. Bioorg Med Chem 23:5829\u20135838","journal-title":"Bioorg Med Chem"},{"key":"1301_CR70","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acs.molpharmaceut.5b00098","volume":"12","author":"G Costabile","year":"2015","unstructured":"Costabile G, d\u2019Angelo I, Rampioni G, Bond\u00ec R, Pompili B, Ascenzioni F, Mitidieri E, di Villa D, Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F (2015) Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: Development of inhalable formulations through nanosuspension technology. Mol Pharm 12:2604\u20132617","journal-title":"Mol Pharm"},{"key":"1301_CR71","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/jof8050536","volume":"8","author":"V Fichman","year":"2022","unstructured":"Fichman V, Mota-Damasceno CG, Proc\u00f3pio-Azevedo AC, Almeida-Silva F, de Macedo PM, Medeiros DM, Astacio GSM, Zancop\u00e9-Oliveira RM, Almeida-Paes R, Freitas DFS, Gutierrez-Galhardo MC (2022) Pulmonary sporotrichosis caused by Sporothrix brasiliensis: A 22-year, single-center, retrospective cohort study. J Fungi 8:536","journal-title":"J Fungi"},{"key":"1301_CR72","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/cbic.201700500","volume":"19","author":"E Barini","year":"2018","unstructured":"Barini E, Miccoli A, Tinarelli F, Mulholland K, Kadri H, Khanim F, Stojanovski L, Read KD, Burness K, Blow JJ, Mehellou Y, Muqit MMK (2018) The anthelmintic drug niclosamide and its analogues activate the parkinson\u2019s disease associated protein kinase PINK1. ChemBioChem 19:425\u2013429","journal-title":"ChemBioChem"},{"key":"1301_CR73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jof9010017","volume":"9","author":"MA Lima","year":"2022","unstructured":"Lima MA, Freitas DFS, Oliveira RVC, Fichman V, Varon AG, Freitas AD, Lamas CC, Andrade HB, Veloso VG, Almeida-Paes R, Almeida-Silva F, Zancop\u00e9-Oliveira RM, de Macedo PM, Valle ACF, Silva MTT, Ara\u00fajo AQC, Gutierrez-Galhardo MC (2022) Meningeal sporotrichosis due to Sporothrix brasiliensis: A 21-year cohort study from a brazilian reference center. J Fungi 9:17","journal-title":"J Fungi"},{"key":"1301_CR74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.riam.2009.02.005","volume":"26","author":"H Madrid","year":"2009","unstructured":"Madrid H, Cano J, Gen\u00e9 J, Bonifaz A, Toriello C, Guarro J (2009) Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol 26:218\u2013222","journal-title":"Rev Iberoam Micol"},{"key":"1301_CR75","doi-asserted-by":"crossref","first-page":"e00286","DOI":"10.1128\/AAC.00286-20","volume":"64","author":"HC Oliveira","year":"2020","unstructured":"Oliveira HC, Joffe LS, Simon KS, Castelli RF, Reis FCG, Bryan AM, Borges BS, Medeiros LCS, Bocca AL, Del Poeta M, Rodrigues ML (2020) Fenbendazole controls in vitro growth, virulence potential, and animal infection in the Cryptococcus model. Antimicrob Agents Chemother 64:e00286-e320","journal-title":"Antimicrob Agents Chemother"},{"key":"1301_CR76","doi-asserted-by":"crossref","first-page":"e02539","DOI":"10.1128\/AEM.02539-20","volume":"87","author":"R Garcia-Rubio","year":"2021","unstructured":"Garcia-Rubio R, Gonzalez-Jimenez I, Lucio J, Mellado E (2021) Characterization of Aspergillus fumigatus cross-resistance between clinical and DMI azole drugs. Appl Environ Microbiol 87:e02539-e2620","journal-title":"Appl Environ Microbiol"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-024-01301-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T02:12:39Z","timestamp":1717639959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-024-01301-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1301"],"URL":"https:\/\/doi.org\/10.1007\/s42770-024-01301-5","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]},"assertion":[{"value":"31 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}